Pharmacokinetic properties of paeoniflorin, albiflorin and oxypaeoniflorin after oral gavage of extracts of Radix Paeoniae Rubra and Radix Paeoniae Alba in rats

被引:76
作者
Feng, Chao [1 ]
Liu, Man [1 ]
Shi, Xiaowei [1 ]
Yang, Wei [1 ]
Kong, Dezhi [1 ]
Duan, Kunfeng [1 ]
Wang, Qiao [1 ]
机构
[1] Hebei Med Univ, Sch Pharm, Dept Pharmaceut Anal, Shijiazhuang 050017, Peoples R China
关键词
Pharmacokinetic; Radix Paeoniae Rubra; Radix Paeoniae Alba; HPLC-ESI-MS; DECOCTION;
D O I
10.1016/j.jep.2010.05.028
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Aim of the study: To establish a HPLC-MS method and investigate the pharmacokinetic properties of paeoniflorin, albiflorin and oxypaeoniflorin and the pharmacokinetics difference of Radix Paeoniae Rubra and Radix Paeoniae Alba. Materials and methods: The extracts of Radix Paeoniae Rubra and Radix Paeoniae Alba were separately administrated to rats. The concentrations of paeoniflorin, albiflorin and oxypaeoniflorin in rat plasma were determined by HPLC-ESI-MS method. The plasma samples were pretreated by protein precipitation with methanol and chromatographic separation was performed on a C-18 column with a mobile phase consisted of 0.1% formic acid and methanol (67:33, v/v). The detection was accomplished by multiple-reaction monitoring (MRM) scanning via electrospray ionization (ESI) source operating in the negative ionization mode. Main pharmacokinetic parameters were estimated and the total AUC of the three components were compared. Results: The pharmacokinetic parameters of paeoniflorin, albiflorin and oxypaeoniflorin were significantly different. There was significant difference between the pharmacokinetic characteristics of Radix Paeoniae Rubra and Radix Paeoniae Alba. Conclusions: A specific and sensitive HPLC-ESI-MS method was developed for simultaneous determination of paeoniflorin, albiflorin and oxypaeoniflorin in rat plasma and was successfully applied to pharmacokinetic study. The results might be helpful for the investigation of different effects of Radix Paeoniae Rubra and Radix Paeoniae Alba. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:407 / 413
页数:7
相关论文
共 12 条
[1]   Chemical profiling of Radix Paeoniae evaluated by ultra-performance liquid chromatography/photo-diode-array/quadrupole time-of-flight mass spectrometry [J].
Li, Song-Lin ;
Song, Jing-Zheng ;
Choi, Franky F. K. ;
Qiao, Chun-Feng ;
Zhou, Yan ;
Han, Quan-Bin ;
Xu, Hong-Xi .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (02) :253-266
[2]   Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS [J].
Matuszewski, BK ;
Constanzer, ML ;
Chavez-Eng, CM .
ANALYTICAL CHEMISTRY, 2003, 75 (13) :3019-3030
[3]  
National Pharmacopoeia Committee, 2020, COMM PHARM PR CHIN 1
[4]   Comparative pharmacokinetic study of paeoniflorin after oral administration of decoction of Radix Paeoniae Rubra and Radix Paeoniae Alba in rats [J].
Wang, Chang-hong ;
Wang, Rui ;
Cheng, Xue-mei ;
He, Yu-qi ;
Wang, Zheng-tao ;
Wu, Cheng ;
Cao, Jing .
JOURNAL OF ETHNOPHARMACOLOGY, 2008, 117 (03) :467-472
[5]  
[王巧 WANG Qiao], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1170
[6]  
Wu Jie, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2369
[7]  
XIANG Q, 1999, J SHENYANG PHARM U, V16, P250
[8]   Paeoniflorin:: an antihyperlipidemic agent from Paeonia lactiflora [J].
Yang, HO ;
Ko, WK ;
Kim, JY ;
Ro, HS .
FITOTERAPIA, 2004, 75 (01) :45-49
[9]  
Ye G, 2003, J PHARMACEUT BIOMED, V33, P521, DOI [10.1016/S0731-7085(03)00294-2, 10.1016/s0731-7085(03)00294-2]
[10]  
Zhang X.Y., 2001, J SHENYANG PHARM U, V18, P27